Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 09741063 Mrs RA Bryant Mr RC Bryant iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09741063 2024-03-31 09741063 2025-03-31 09741063 2024-04-01 2025-03-31 09741063 frs-core:CurrentFinancialInstruments 2025-03-31 09741063 frs-core:RevaluationReserve 2024-04-01 2025-03-31 09741063 frs-core:RevaluationReserve 2025-03-31 09741063 frs-core:ShareCapital 2025-03-31 09741063 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 09741063 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09741063 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 09741063 frs-bus:SmallEntities 2024-04-01 2025-03-31 09741063 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09741063 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09741063 frs-core:UnlistedNon-exchangeTraded 2025-03-31 09741063 frs-core:UnlistedNon-exchangeTraded 2024-03-31 09741063 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 09741063 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 09741063 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 09741063 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-03-31 09741063 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 09741063 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 09741063 frs-bus:Director1 2024-04-01 2025-03-31 09741063 frs-bus:Director2 2024-04-01 2025-03-31 09741063 frs-countries:EnglandWales 2024-04-01 2025-03-31 09741063 2023-03-31 09741063 2024-03-31 09741063 2023-04-01 2024-03-31 09741063 frs-core:CurrentFinancialInstruments 2024-03-31 09741063 frs-core:RevaluationReserve 2024-03-31 09741063 frs-core:ShareCapital 2024-03-31 09741063 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 09741063
Bryant Orthopaedics Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 09741063
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 4 292,410 200,000
292,410 200,000
CURRENT ASSETS
Debtors 5 27,215 11,492
Cash at bank and in hand 289,847 352,861
317,062 364,353
Creditors: Amounts Falling Due Within One Year 6 (40,744 ) (40,199 )
NET CURRENT ASSETS (LIABILITIES) 276,318 324,154
TOTAL ASSETS LESS CURRENT LIABILITIES 568,728 524,154
NET ASSETS 568,728 524,154
CAPITAL AND RESERVES
Called up share capital 7 600 500
Revaluation reserve 8 (7,724 ) -
Profit and Loss Account 575,852 523,654
SHAREHOLDERS' FUNDS 568,728 524,154
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr RC Bryant
Director
19/09/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Bryant Orthopaedics Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 09741063 . The registered office is Lea Bank Farm, Loxley Road, Loxley, Sheffield, S6 6RW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Investments
Unlisted
£
Cost or Valuation
As at 1 April 2024 200,000
Additions 100,134
Revaluations (7,724 )
As at 31 March 2025 292,410
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 292,410
As at 1 April 2024 200,000
5. Debtors
2025 2024
£ £
Due within one year
Trade debtors 12,561 10,420
Prepayments and accrued income 14,540 1,072
Other debtors 114 -
27,215 11,492
Page 3
Page 4
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Corporation tax 20,731 24,061
Other creditors 10,000 3,000
Accruals and deferred income 5,867 7,256
Directors' loan accounts 4,146 5,882
40,744 40,199
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 600 500
8. Reserves
Revaluation Reserve
£
Transfer to profit and loss (7,724 )
As at 31 March 2025 (7,724 )
Page 4